Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate abnormal dopamine synthesis and connectivity according to the antipsychotic treatment response in schizophrenia.
Age
20 - 55 years
Sex
ALL
Healthy Volunteers
Yes
Seoul National University Hospital
Seoul, South Korea
Start Date
May 1, 2014
Primary Completion Date
May 1, 2016
Completion Date
May 1, 2016
Last Updated
April 8, 2019
36
ACTUAL participants
patients treated with antipsychotics
OTHER
Lead Sponsor
Seoul National University Hospital
NCT07455929
NCT06740383
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions